Harvard University
Cambridge, Massachusetts, 02138, United States
NCT Number: NCT03112304
The overarching goal of this project is to study the sustainability of MATCH-ADTC within community mental health clinics, to learn what is needed for evidence-based practices (EBPs) to take root and thrive within a public system.
Looking for future studies?
Notify Me6 year–15 year
All sexes
Interventional
Not applicable
Cambridge, Massachusetts, 02138, United States
In this project, the investigators are randomizing children to Wave 1 (previously MATCH trained) or Wave 2 (newly MATCH trained) and using a clinical monitoring system (TRAC) to measure youth outcomes over time. Participating therapists receive weekly MATCH consultation provided by the Judge Baker Children's Center/Harvard University research team or by Maine clinic supervisors who are MATCH Associate Consultants. The investigators are also developing and testing new low-cost measures of MATCH treatment and consultation fidelity to explore the feasibility of more sustainable measures of MATCH adherence. Study data will be used to answer questions about the sustainability of MATCH in the public sector.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MATCH - ADTC (Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems; Chorpita & Weisz, 2009) is a psychosocial intervention designed to treat children with multiple disorders and problems encompassing anxiety, depression, post-traumatic stress, and disruptive conduct, including the conduct problems associated with ADHD. It is recommended for children aged 6-15. MATCH is composed of 33 modules-i.e., specific treatment procedures derived from decades of research on EBTs. The various modules can be organized and sequenced flexibly to tailor treatment to each child's characteristics and needs.
Other names: MATCH
TRAC (Treatment Response Assessment for Children) is a web-based system that provides weekly monitoring of the MATCH modules used and the child's response to treatment. Child's response to treatment is based on caregiver and child reports of (a) changes in problem severity on the standardized Brief Problem Checklist, and (b) changes in severity of the top treatment concerns identified by youths and caregivers. At the end of treatment, TRAC provides a complete record of modules used, and child treatment response, across all the weeks of treatment, as illustrated in the "client dashboard."
Time frame: Change over time from Day 1 to Day 242 (end of treatment)
Time frame: Change over time from Day 1 to Day 534 (18 month follow-up)
Time frame: Change over time from Day 1 to Day 534 (18 month follow-up)
Time frame: Change over time from Day 1 to Day 267(end of treatment)
Time frame: Change over time from Day 1 to Day 267(end of treatment)
Time frame: Change over time from Day 1 to Day 267(end of treatment)
Time frame: Change over time from Day 1 to Day 267(end of treatment)
Time frame: Change over time from Day 1 to Day 267(end of treatment)
Harvard University
Other
Child STEPS for Youth Mental Health in Maine: Sustainability of MATCH in the Public Sector
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02877875
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT03112265
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT03153904
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT04725721
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial Details